首页 | 本学科首页   官方微博 | 高级检索  
     

糖皮质激素炎症通路研究现状
引用本文:赵珂,刘向祎. 糖皮质激素炎症通路研究现状[J]. 大连医科大学学报, 2021, 43(1): 84-88. DOI: 10.11724/jdmu.2021.01.16
作者姓名:赵珂  刘向祎
作者单位:首都医科大学附属北京同仁医院检验科,北京100730;首都医科大学附属北京同仁医院检验科,北京100730
基金项目:北京市卫生系统高层次卫生技术人才项目(2015-3-014)
摘    要:糖皮质激素(glucocorticoid,GC)由于其强大的抗炎和免疫抑制等作用被广泛应用于临床.但是,随着对GC认识的深入,研究者们发现GC还能发挥促炎作用,这种效应甚至是机体活动所必须的.机体对GC的反应取决于GC的浓度、机体免疫系统的生理状态、刺激持续时间(急性或慢性)以及疾病的类型等.此外,越来越多的患者出现了...

关 键 词:糖皮质激素  糖皮质激素受体  炎症因子
收稿时间:2020-05-27
修稿时间:2021-01-19

Research status of glucocorticoid inflammatory pathways
ZHAO Ke,LIU Xiangyi. Research status of glucocorticoid inflammatory pathways[J]. Journal of Dalian Medical University, 2021, 43(1): 84-88. DOI: 10.11724/jdmu.2021.01.16
Authors:ZHAO Ke  LIU Xiangyi
Affiliation:Department of Clinical Laboratory, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
Abstract:Glucocorticoid (GC) is widely used clinically due to its powerful anti-inflammatory and immunosuppressive effects. However, with its deeper understanding, researchers have found that GC can also play pro-inflammatory effects, which is even necessary for body activity. The body''s response to GC depends on the concentration of GC, the physiological state of the body''s immune system, the duration of stimulation (acute or chronic), and the type of disease. In addition, more and more patients have poor or even no response to GC, which is often clinically referred as glucocorticoid resistance (GCR). Both glucocorticoid receptor (GR) and downstream inflammatory factors in the GC inflammation pathway may cause GCR. This article reviews the current research status of GC inflammatory pathways.
Keywords:glucocorticoid  glucocorticoid receptor  inflammatory factors
本文献已被 万方数据 等数据库收录!
点击此处可从《大连医科大学学报》浏览原始摘要信息
点击此处可从《大连医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号